Ocugen, Inc. Common Stock (OCGN) is a publicly traded Healthcare sector company. As of July 13, 2026, OCGN trades at $1.44 with a market cap of $497.63M and a P/E ratio of 0.00. OCGN moved -2.72% today. Year to date, OCGN is +7.30%; over the trailing twelve months it is +27.83%. Its 52-week range spans $0.52 to $2.73. Analyst consensus is strong buy with an average price target of $9.67. Rallies surfaces OCGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for OCGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.44 |
| Market Cap | $497.63M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.73 |
| 52-Week Low | $0.52 |
| Volume | 1.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.41M |
| Net Income | $-67.85M |
| Gross Margin | 0.00% |
6 analysts cover OCGN: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.67.